Adenuric (febuxostat) 80mg and 120mg tablets are indicated for the treatment of chronic hyperuricaemia for conditions in which urate deposition has already occurred (including a history, or presence
Marketing applications for the use of alitretinoin in the treatment of severe chronic refractory hand eczema are also under regulatory review in several EU member states and in
This amalgamation completes the process of integrating the small cell lung cancer (SCLC) molecule library of DDP with the research development operations of Critical Outcome Technologies (COTI). Since
In April 2008, the European Medicines Agency (EMEA) accepted for review the company’s marketing authorization application (MAA) for Opaxio (paclitaxel poliglumex, CT-2103) for first-line treatment of patients with
These drugs, especially hydrocodone and alprazolam, have come under increased US Drug Enforcement Administration (DEA) scrutiny in recent months because of their potential for abuse. The administrative settlement,
Roche’s exercise of its option triggers a $6 million milestone payment and entitles Memory to future payments upon the achievement of additional milestones and royalties on product sales,
Mpathy has appointed George Borthwick, former president of Ethicon in Europe, as non-executive chairman, and Ian Stevens, formerly CFO and US general manager at Optos, as CEO. Ian
This randomized, double-blind study has demonstrated that motavizumab reduced hospitalizations due to respiratory syncytial virus (RSV) by 83% as compared to placebo (8.3% in placebo arm versus 1.4%
St Jude Medical and Microsoft will work with physicians to determine the optimal level of integration (between the Merlin.net Patient Care Network and Microsoft HealthVault) that will allow
In exchange for each outstanding share of Renovis common stock, Renovis stockholders receive 0.5271 American depositary shares (ADSs) of Evotec. Each Evotec ADS represents two ordinary shares of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.